Suppr超能文献

EFSUMB 技术评论-2023 更新:用于量化肿瘤灌注的动态对比增强超声(DCE-CEUS)。

EFSUMB Technical Review - Update 2023: Dynamic Contrast-Enhanced Ultrasound (DCE-CEUS) for the Quantification of Tumor Perfusion.

机构信息

Department General Internal Medicine, Kliniken Hirslanden Beau Site, Salem und Permanence, Bern, Switzerland.

Zentrum der Inneren Medizin, Johann Wolfgang Goethe Universitätsklinik Frankfurt, Frankfurt, Germany.

出版信息

Ultraschall Med. 2024 Feb;45(1):36-46. doi: 10.1055/a-2157-2587. Epub 2023 Sep 25.

Abstract

Dynamic contrast-enhanced ultrasound (DCE-US) is a technique to quantify tissue perfusion based on phase-specific enhancement after the injection of microbubble contrast agents for diagnostic ultrasound. The guidelines of the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) published in 2004 and updated in 2008, 2011, and 2020 focused on the use of contrast-enhanced ultrasound (CEUS), including essential technical requirements, training, investigational procedures and steps, guidance regarding image interpretation, established and recommended clinical indications, and safety considerations. However, the quantification of phase-specific enhancement patterns acquired with ultrasound contrast agents (UCAs) is not discussed here. The purpose of this EFSUMB Technical Review is to further establish a basis for the standardization of DCE-US focusing on treatment monitoring in oncology. It provides some recommendations and descriptions as to how to quantify dynamic ultrasound contrast enhancement, and technical explanations for the analysis of time-intensity curves (TICs). This update of the 2012 EFSUMB introduction to DCE-US includes clinical aspects for data collection, analysis, and interpretation that have emerged from recent studies. The current study not only aims to support future work in this research field but also to facilitate a transition to clinical routine use of DCE-US.

摘要

动态对比增强超声(DCE-US)是一种基于注射微泡对比剂后相位特异性增强来定量组织灌注的技术,用于诊断超声。欧洲超声医学和生物学联合会(EFSUMB)于 2004 年发布并于 2008 年、2011 年和 2020 年更新的指南,重点关注对比增强超声(CEUS)的使用,包括基本技术要求、培训、研究程序和步骤、图像解释指导、已确立和推荐的临床适应证以及安全性考虑。然而,这里没有讨论使用超声对比剂(UCAs)获得的相位特异性增强模式的定量。本 EFSUMB 技术评论的目的是进一步为 DCE-US 的标准化建立基础,重点关注肿瘤治疗监测。它提供了一些关于如何量化动态超声对比增强的建议和描述,以及分析时间强度曲线(TICs)的技术解释。本研究不仅旨在支持该研究领域的未来工作,还旨在促进 DCE-US 向临床常规应用的转变。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验